Ingredion (NYSE:INGR) Upgraded at Stephens

Stephens upgraded shares of Ingredion (NYSE:INGR) to a hold rating in a research note issued to investors on Monday,Zacks.com reports.

Other equities analysts have also issued reports about the company. Barclays upped their target price on Ingredion from $145.00 to $168.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer upped their target price on Ingredion from $147.00 to $178.00 and gave the company an “outperform” rating in a report on Wednesday, November 6th. BMO Capital Markets upped their target price on Ingredion from $128.00 to $147.00 and gave the company a “market perform” rating in a report on Wednesday, November 6th. UBS Group upped their target price on Ingredion from $165.00 to $173.00 and gave the company a “buy” rating in a report on Friday, November 15th. Finally, StockNews.com lowered Ingredion from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $155.17.

Ingredion Stock Performance

Shares of Ingredion stock opened at $149.41 on Monday. Ingredion has a one year low of $104.68 and a one year high of $155.44. The firm has a market capitalization of $9.74 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 1.28 and a beta of 0.74. The business has a 50-day simple moving average of $140.39 and a 200 day simple moving average of $129.19. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.67 and a quick ratio of 1.69.

Ingredion (NYSE:INGR) last issued its earnings results on Tuesday, November 5th. The company reported $3.05 EPS for the quarter, beating analysts’ consensus estimates of $2.58 by $0.47. The business had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.94 billion. Ingredion had a return on equity of 17.75% and a net margin of 9.05%. The firm’s revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.33 EPS. On average, research analysts anticipate that Ingredion will post 10.6 earnings per share for the current fiscal year.

Insider Transactions at Ingredion

In related news, CFO James D. Gray sold 54,869 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $146.76, for a total value of $8,052,574.44. Following the transaction, the chief financial officer now owns 12,795 shares of the company’s stock, valued at $1,877,794.20. This represents a 81.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO James P. Zallie sold 371 shares of the stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $133.58, for a total value of $49,558.18. Following the completion of the transaction, the chief executive officer now directly owns 52,159 shares in the company, valued at approximately $6,967,399.22. This represents a 0.71 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 66,197 shares of company stock valued at $9,702,315. 1.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of INGR. Cetera Advisors LLC grew its stake in shares of Ingredion by 60.6% during the first quarter. Cetera Advisors LLC now owns 4,864 shares of the company’s stock valued at $568,000 after buying an additional 1,835 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Ingredion by 102.6% during the first quarter. EverSource Wealth Advisors LLC now owns 233 shares of the company’s stock worth $27,000 after purchasing an additional 118 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Ingredion by 127.3% during the second quarter. GAMMA Investing LLC now owns 600 shares of the company’s stock worth $69,000 after purchasing an additional 336 shares during the period. CWM LLC boosted its holdings in shares of Ingredion by 59.7% during the second quarter. CWM LLC now owns 3,923 shares of the company’s stock worth $450,000 after purchasing an additional 1,467 shares during the period. Finally, Aspire Private Capital LLC boosted its holdings in shares of Ingredion by 21.6% during the second quarter. Aspire Private Capital LLC now owns 3,213 shares of the company’s stock worth $369,000 after purchasing an additional 571 shares during the period. 85.27% of the stock is owned by institutional investors.

Ingredion Company Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.